SCHEMBL2892528

SCHEMBL2892528

CC1(C)CC1CCC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGT2B7 P16662 2/20 0.39
LMNA P02545 4/20 0.36
ALKBH5 Q6P6C2 1/20 0.36
SUCNR1 Q9BXA5 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
FFAR3 O14843 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
APLNR P35414 1/20 0.36
SLC15A2 Q16348 1/20 0.35
GRM2 Q14416 2/20 0.34
GRM5 P41594 1/20 0.34
GRM1 Q13255 1/20 0.34
ALOX5 P09917 1/20 0.34
SLC22A6 Q4U2R8 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HTT P42858 1/20 0.33
FOLH1 Q04609 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1536541 0.85 LMNA (0.46) LMNAALOX5SLC22A6AKR1B1TSHR
SCHEMBL23533413 0.83 TSHR (0.48) LMNAALOX5SLC22A6TSHRNFKB1
SCHEMBL10924973 0.75
SCHEMBL16084399 0.75
SCHEMBL14465121 0.73 ALDH1A1 (0.31) UGT2B7TSHR
SCHEMBL5691355 0.70 UGT2B7 (0.36) UGT2B7FOLH1
Bicarbonate SCHEMBL11272732 0.70 APLNR (0.39) LMNAFFAR3APLNRGRM2GRM5
SCHEMBL16060618 0.69
SCHEMBL16134934 0.69
SCHEMBL13409658 0.69 ALDH1A1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286073-A1 COMPOUNDS AND METHODS FOR PHARMACEUTICAL USE GENERICS (UK) LIMITED (GB) 2010-11-11 US claimed
EP-2205229-A1 COMPOUNDS AND METHODS FOR PHARMACEUTICAL USE Mintails Limited (CY) 2010-07-14 EP claimed
WO-2009044202-A1 COMPOUNDS AND METHODS FOR PHARMACEUTICAL USE MINTAILS LIMITED (CY) 2009-04-09 WO claimed
US-20100286073-A1 COMPOUNDS AND METHODS FOR PHARMACEUTICAL USE GENERICS (UK) LIMITED (GB) 2010-11-11 US disclosed
EP-2205229-A1 COMPOUNDS AND METHODS FOR PHARMACEUTICAL USE Mintails Limited (CY) 2010-07-14 EP disclosed
WO-2009044202-A1 COMPOUNDS AND METHODS FOR PHARMACEUTICAL USE MINTAILS LIMITED (CY) 2009-04-09 WO disclosed